However, loss of function mutations involving NFAT has not been reported in spontaneous cases of either human or murine T-ALL; thus, the tumour suppressive activity of NFATc1 may be specific to the background of the additional oncogenic events. The gene discussed is NFATC1; the disease is neoplasm.